HCV POLYMERASE INHIBITORS

The present invention provides compounds of the formulawherein B is a nucleobase selected from the groups (a)-(b)and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects. В изобретении представлены соед...

Full description

Saved in:
Bibliographic Details
Main Authors TORSSELL Staffan, KALAYANOV Genadiy, WAEHLING Horst
Format Patent
LanguageEnglish
Russian
Published 31.01.2018
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides compounds of the formulawherein B is a nucleobase selected from the groups (a)-(b)and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects. В изобретении представлены соединения, характеризующиеся формулойгде B представляет собой нуклеотидное основание, выбранное из групп (a) и (b)а другие переменные указаны в формуле изобретения, которые пригодны при лечении или профилактике вируса гепатита C, а также связанных с этим аспектов.
Bibliography:Application Number: EA20160090452